Skip to main content
SpringerLink
Log in

Comment on: Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals Analysis of Trends in Dispensing Patterns in The Netherlands from 1998 to 2008

  • Letter to the Editor
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ruiter R, Visser LE, van Herk-Sukel MPP, Geelhoed-Duijvestijn PH, de Bie S, et al. Prescribing of rosiglitazone and pioglitazone following safety signals analysis of trends in dispensing patterns in The Netherlands from 1998 to 2008. Drug Saf. 2012;35(6):471–80.

  2. Leal I, Romio SA, Schuemie M, Oteri A, Sturkenboom M, Trifirò G. Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone. Br J Clin Pharmacol. 2013;75(3):861–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  3. Carracedo-Martínez E, Pia-Morandeira A, Figueiras A. Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study. Pharmacoepidemiol Drug Saf. 2012;21(3):281–4.

    Article  PubMed  Google Scholar 

  4. Exmedica. Zorgverzekeraar controleert streng op vergoeden diabetesmidelen. 2007. http://www.exmedica.nl/nieuws/2007/06/zorgverzekeraar-controleert-streng-op-vergoeden. Accessed 12 Aug 2014.

Download references

Funding and conflicts of interest

No sources of funding were used to assist in the preparation of this study. Eduardo Carracedo-Martínez has no conflicts of interest that are directly relevant to the content of this study.

Author information

Authors and Affiliations

  1. Santiago of Compostela Health Area, Galician Health Service (Servizo Galego de Saude (Sergas)), Spanish National Health System, Apartado de Correos 466, Santiago de Compostela, A Coruña, Spain

    Eduardo Carracedo-Martínez

Authors
  1. Eduardo Carracedo-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo Carracedo-Martínez.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carracedo-Martínez, E. Comment on: Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals Analysis of Trends in Dispensing Patterns in The Netherlands from 1998 to 2008. Drug Saf 37, 1069–1070 (2014). https://doi.org/10.1007/s40264-014-0227-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40264-014-0227-y

Keywords

Search

Navigation